 | • レポートコード：MRC2-11QY01145 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヘルペス治療のグローバル市場について調査・分析したレポートです。種類別（アシクロビル、バラシクロビル、ファムシクロビル）市場規模、用途別（病院薬局、小売薬局、オンライン薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヘルペス治療の競争状況、市場シェア ・世界のヘルペス治療市場：種類別市場規模 2015年-2020年（アシクロビル、バラシクロビル、ファムシクロビル） ・世界のヘルペス治療市場：種類別市場規模予測 2021年-2026年（アシクロビル、バラシクロビル、ファムシクロビル） ・世界のヘルペス治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・世界のヘルペス治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・北米のヘルペス治療市場分析：米国、カナダ ・ヨーロッパのヘルペス治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヘルペス治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヘルペス治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヘルペス治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Gilead、GlaxoSmithKline、Merck、Novartis、Abbott、Mylan、Teva Pharmaceutical Industries、Vical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2.
The rising prevalence of shingles or herpes zoster in the older population is one of the key drivers responsible for the market’s growth. According to the center for disease control and prevention (CDC), almost one in every three individuals in the US are likely to develop shingles during their lifetime. People aged 50 years and above can develop this disease due to weakened immune system. Complications associated with this disease such as post-herpetic neuralgia (PHN) can cause severe pain in the areas where the rashes occurred due to shingles. People administered with immunosuppressants in the past can also develop the disease. CDC recommends that one dose of the zoster vaccine must be prescribed to adults who are 60 years and above to reduce the probability of the disease and PHN. This will drive the demand for drugs for virus types such as herpes simplex and herpes zoster, subsequently fueling market growth.
Market Analysis and Insights: Global Herpes Treatment Market
The global Herpes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Herpes Treatment Scope and Market Size
Herpes Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Herpes Treatment market is segmented into
Acyclovir
Valacyclovir
Famciclovir
Segment by Application, the Herpes Treatment market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Regional and Country-level Analysis
The Herpes Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Herpes Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Herpes Treatment Market Share Analysis
Herpes Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Herpes Treatment business, the date to enter into the Herpes Treatment market, Herpes Treatment product introduction, recent developments, etc.
The major vendors covered:
Gilead
GlaxoSmithKline
Merck
Novartis
Abbott
Mylan
Teva Pharmaceutical Industries
Vical
1 Study Coverage
1.1 Herpes Treatment Product Introduction
1.2 Market Segments
1.3 Key Herpes Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Herpes Treatment Market Size Growth Rate by Type
1.4.2 Acyclovir
1.4.3 Valacyclovir
1.4.4 Famciclovir
1.5 Market by Application
1.5.1 Global Herpes Treatment Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Herpes Treatment Market Size, Estimates and Forecasts
2.1.1 Global Herpes Treatment Revenue 2015-2026
2.1.2 Global Herpes Treatment Sales 2015-2026
2.2 Global Herpes Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Herpes Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Herpes Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Herpes Treatment Competitor Landscape by Players
3.1 Herpes Treatment Sales by Manufacturers
3.1.1 Herpes Treatment Sales by Manufacturers (2015-2020)
3.1.2 Herpes Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Herpes Treatment Revenue by Manufacturers
3.2.1 Herpes Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Herpes Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Herpes Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Herpes Treatment Revenue in 2019
3.2.5 Global Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Herpes Treatment Price by Manufacturers
3.4 Herpes Treatment Manufacturing Base Distribution, Product Types
3.4.1 Herpes Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Herpes Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Herpes Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Herpes Treatment Market Size by Type (2015-2020)
4.1.1 Global Herpes Treatment Sales by Type (2015-2020)
4.1.2 Global Herpes Treatment Revenue by Type (2015-2020)
4.1.3 Herpes Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Herpes Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Herpes Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Herpes Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Herpes Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Herpes Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Herpes Treatment Market Size by Application (2015-2020)
5.1.1 Global Herpes Treatment Sales by Application (2015-2020)
5.1.2 Global Herpes Treatment Revenue by Application (2015-2020)
5.1.3 Herpes Treatment Price by Application (2015-2020)
5.2 Herpes Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Herpes Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Herpes Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Herpes Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Herpes Treatment by Country
6.1.1 North America Herpes Treatment Sales by Country
6.1.2 North America Herpes Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Herpes Treatment Market Facts & Figures by Type
6.3 North America Herpes Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Herpes Treatment by Country
7.1.1 Europe Herpes Treatment Sales by Country
7.1.2 Europe Herpes Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Herpes Treatment Market Facts & Figures by Type
7.3 Europe Herpes Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Herpes Treatment by Region
8.1.1 Asia Pacific Herpes Treatment Sales by Region
8.1.2 Asia Pacific Herpes Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Herpes Treatment Market Facts & Figures by Type
8.3 Asia Pacific Herpes Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Herpes Treatment by Country
9.1.1 Latin America Herpes Treatment Sales by Country
9.1.2 Latin America Herpes Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Herpes Treatment Market Facts & Figures by Type
9.3 Central & South America Herpes Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Herpes Treatment by Country
10.1.1 Middle East and Africa Herpes Treatment Sales by Country
10.1.2 Middle East and Africa Herpes Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Herpes Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Herpes Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Corporation Information
11.1.2 Gilead Description and Business Overview
11.1.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gilead Herpes Treatment Products Offered
11.1.5 Gilead Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Herpes Treatment Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Herpes Treatment Products Offered
11.3.5 Merck Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Herpes Treatment Products Offered
11.4.5 Novartis Related Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description and Business Overview
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Herpes Treatment Products Offered
11.5.5 Abbott Related Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Description and Business Overview
11.6.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Mylan Herpes Treatment Products Offered
11.6.5 Mylan Related Developments
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Corporation Information
11.7.2 Teva Pharmaceutical Industries Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Herpes Treatment Products Offered
11.7.5 Teva Pharmaceutical Industries Related Developments
11.8 Vical
11.8.1 Vical Corporation Information
11.8.2 Vical Description and Business Overview
11.8.3 Vical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Vical Herpes Treatment Products Offered
11.8.5 Vical Related Developments
11.1 Gilead
11.1.1 Gilead Corporation Information
11.1.2 Gilead Description and Business Overview
11.1.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gilead Herpes Treatment Products Offered
11.1.5 Gilead Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Herpes Treatment Market Estimates and Projections by Region
12.1.1 Global Herpes Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Herpes Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Herpes Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Herpes Treatment Sales Forecast (2021-2026)
12.2.2 North America: Herpes Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Herpes Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Herpes Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Herpes Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Herpes Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Herpes Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Herpes Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Herpes Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Herpes Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Herpes Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Herpes Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Herpes Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Herpes Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Herpes Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Herpes Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Herpes Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Herpes Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Herpes Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Herpes Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Herpes Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Herpes Treatment Market Segments
Table 2. Ranking of Global Top Herpes Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Herpes Treatment Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Acyclovir
Table 5. Major Manufacturers of Valacyclovir
Table 6. Major Manufacturers of Famciclovir
Table 7. Global Herpes Treatment Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Herpes Treatment Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Herpes Treatment Sales by Regions 2015-2020 (K MT)
Table 10. Global Herpes Treatment Sales Market Share by Regions (2015-2020)
Table 11. Global Herpes Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Herpes Treatment Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Herpes Treatment Sales Share by Manufacturers (2015-2020)
Table 14. Global Herpes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Herpes Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Treatment as of 2019)
Table 16. Herpes Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Herpes Treatment Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Herpes Treatment Price (2015-2020) (USD/MT)
Table 19. Herpes Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Herpes Treatment Product Type
Table 21. Date of International Manufacturers Enter into Herpes Treatment Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Herpes Treatment Sales by Type (2015-2020) (K MT)
Table 24. Global Herpes Treatment Sales Share by Type (2015-2020)
Table 25. Global Herpes Treatment Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Herpes Treatment Revenue Share by Type (2015-2020)
Table 27. Herpes Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Herpes Treatment Sales by Application (2015-2020) (K MT)
Table 29. Global Herpes Treatment Sales Share by Application (2015-2020)
Table 30. North America Herpes Treatment Sales by Country (2015-2020) (K MT)
Table 31. North America Herpes Treatment Sales Market Share by Country (2015-2020)
Table 32. North America Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 34. North America Herpes Treatment Sales by Type (2015-2020) (K MT)
Table 35. North America Herpes Treatment Sales Market Share by Type (2015-2020)
Table 36. North America Herpes Treatment Sales by Application (2015-2020) (K MT)
Table 37. North America Herpes Treatment Sales Market Share by Application (2015-2020)
Table 38. Europe Herpes Treatment Sales by Country (2015-2020) (K MT)
Table 39. Europe Herpes Treatment Sales Market Share by Country (2015-2020)
Table 40. Europe Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 42. Europe Herpes Treatment Sales by Type (2015-2020) (K MT)
Table 43. Europe Herpes Treatment Sales Market Share by Type (2015-2020)
Table 44. Europe Herpes Treatment Sales by Application (2015-2020) (K MT)
Table 45. Europe Herpes Treatment Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Herpes Treatment Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Herpes Treatment Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Herpes Treatment Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Herpes Treatment Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Herpes Treatment Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Herpes Treatment Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Herpes Treatment Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Herpes Treatment Sales Market Share by Application (2015-2020)
Table 54. Latin America Herpes Treatment Sales by Country (2015-2020) (K MT)
Table 55. Latin America Herpes Treatment Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 58. Latin America Herpes Treatment Sales by Type (2015-2020) (K MT)
Table 59. Latin America Herpes Treatment Sales Market Share by Type (2015-2020)
Table 60. Latin America Herpes Treatment Sales by Application (2015-2020) (K MT)
Table 61. Latin America Herpes Treatment Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Herpes Treatment Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Herpes Treatment Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Herpes Treatment Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Herpes Treatment Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Herpes Treatment Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Herpes Treatment Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Herpes Treatment Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Herpes Treatment Sales Market Share by Application (2015-2020)
Table 70. Gilead Corporation Information
Table 71. Gilead Description and Major Businesses
Table 72. Gilead Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Gilead Product
Table 74. Gilead Recent Development
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Major Businesses
Table 87. Novartis Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis Product
Table 89. Novartis Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Major Businesses
Table 92. Abbott Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Abbott Product
Table 94. Abbott Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Major Businesses
Table 97. Mylan Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Mylan Product
Table 99. Mylan Recent Development
Table 100. Teva Pharmaceutical Industries Corporation Information
Table 101. Teva Pharmaceutical Industries Description and Major Businesses
Table 102. Teva Pharmaceutical Industries Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceutical Industries Product
Table 104. Teva Pharmaceutical Industries Recent Development
Table 105. Vical Corporation Information
Table 106. Vical Description and Major Businesses
Table 107. Vical Herpes Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Vical Product
Table 109. Vical Recent Development
Table 110. Global Herpes Treatment Sales Forecast by Regions (2021-2026) (K MT)
Table 111. Global Herpes Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Herpes Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Herpes Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Herpes Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 115. North America: Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Herpes Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 117. Europe: Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Herpes Treatment Sales Forecast by Region (2021-2026) (K MT)
Table 119. Asia Pacific: Herpes Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Herpes Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 121. Latin America: Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Herpes Treatment Sales Forecast by Country (2021-2026) (K MT)
Table 123. Middle East and Africa: Herpes Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Herpes Treatment Players
Table 128. Herpes Treatment Customers List
Table 129. Herpes Treatment Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Treatment Product Picture
Figure 2. Global Herpes Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Acyclovir Product Picture
Figure 4. Valacyclovir Product Picture
Figure 5. Famciclovir Product Picture
Figure 6. Global Herpes Treatment Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Drug Stores
Figure 11. Herpes Treatment Report Years Considered
Figure 12. Global Herpes Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Herpes Treatment Sales 2015-2026 (K MT)
Figure 14. Global Herpes Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Herpes Treatment Sales Market Share by Region (2015-2020)
Figure 16. Global Herpes Treatment Sales Market Share by Region in 2019
Figure 17. Global Herpes Treatment Revenue Market Share by Region (2015-2020)
Figure 18. Global Herpes Treatment Revenue Market Share by Region in 2019
Figure 19. Global Herpes Treatment Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Herpes Treatment Revenue in 2019
Figure 21. Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Herpes Treatment Sales Market Share by Type (2015-2020)
Figure 23. Global Herpes Treatment Sales Market Share by Type in 2019
Figure 24. Global Herpes Treatment Revenue Market Share by Type (2015-2020)
Figure 25. Global Herpes Treatment Revenue Market Share by Type in 2019
Figure 26. Global Herpes Treatment Market Share by Price Range (2015-2020)
Figure 27. Global Herpes Treatment Sales Market Share by Application (2015-2020)
Figure 28. Global Herpes Treatment Sales Market Share by Application in 2019
Figure 29. Global Herpes Treatment Revenue Market Share by Application (2015-2020)
Figure 30. Global Herpes Treatment Revenue Market Share by Application in 2019
Figure 31. North America Herpes Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Herpes Treatment Sales Market Share by Country in 2019
Figure 34. North America Herpes Treatment Revenue Market Share by Country in 2019
Figure 35. U.S. Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Herpes Treatment Market Share by Type in 2019
Figure 40. North America Herpes Treatment Market Share by Application in 2019
Figure 41. Europe Herpes Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Herpes Treatment Sales Market Share by Country in 2019
Figure 44. Europe Herpes Treatment Revenue Market Share by Country in 2019
Figure 45. Germany Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Herpes Treatment Market Share by Type in 2019
Figure 56. Europe Herpes Treatment Market Share by Application in 2019
Figure 57. Asia Pacific Herpes Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Herpes Treatment Sales Market Share by Region in 2019
Figure 60. Asia Pacific Herpes Treatment Revenue Market Share by Region in 2019
Figure 61. China Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Herpes Treatment Market Share by Type in 2019
Figure 84. Asia Pacific Herpes Treatment Market Share by Application in 2019
Figure 85. Latin America Herpes Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Herpes Treatment Sales Market Share by Country in 2019
Figure 88. Latin America Herpes Treatment Revenue Market Share by Country in 2019
Figure 89. Mexico Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Herpes Treatment Market Share by Type in 2019
Figure 96. Latin America Herpes Treatment Market Share by Application in 2019
Figure 97. Middle East and Africa Herpes Treatment Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Herpes Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Herpes Treatment Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Herpes Treatment Revenue Market Share by Country in 2019
Figure 101. Turkey Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Herpes Treatment Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Herpes Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Herpes Treatment Market Share by Type in 2019
Figure 108. Middle East and Africa Herpes Treatment Market Share by Application in 2019
Figure 109. North America Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Herpes Treatment Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Herpes Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
口唇ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Herpes Labialis Treatment Scope and Market Size Herpes Labialis…- 帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
- 口唇ヘルペス治療・予防の世界市場（～2026年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Treatment and Prevention of…
- 性器ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Genital Herpes Treatment Market The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Genital Herpes Treatment Scope and Market Size Genital Herpes Tre…
- ヘルペスマーカー検査の世界市場（～2026年） Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial disea…